Spinal Muscular Atrophy Type III Recognized After Delayed Recovery From Neuromuscular Blockade After an Orthognathic Surgery

被引:0
|
作者
Oda, Aya [1 ]
Oue, Kana [1 ,2 ]
Yoshida, Mitsuhiro [1 ]
机构
[1] Hiroshima Univ Hosp, Dept Dent Anesthesiol, Div Oral & Maxillofacial Surg & Oral Med, Hiroshima, Japan
[2] Hiroshima Univ Hosp, Dept Dent Anesthesiol, Div Oral & Max illofacial Surg & Oral Med, Kasumi 1-2-3, Minami ku, Hiroshima 7348551, Japan
关键词
Maxillofacial morphological abnormality; neuromuscular diseases; neuromuscular monitoring; orthognathic surgery; spinal muscular atrophy;
D O I
10.1097/SCS.0000000000009407
中图分类号
R61 [外科手术学];
学科分类号
摘要
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by the degeneration of alpha motor neurons in the spinal cord, resulting in progressive proximal muscle weakness and paralysis. SMA is classified into types I-IV based on the age at symptom onset or maximum motor function achieved, and its clinical manifestations vary. SMA affects maxillofacial growth because of muscle dysfunction and results in abnormal maxillofacial morphology. In addition, definitive diagnosis is not often made because of the older onset age and symptoms are rarely severe. Therefore, the possibility of undiagnosed SMA in craniofacial surgeries must be considered. This report described a case of an SMA type III recognized after delayed recovery from the neuromuscular blockade in an orthognathic surgery under general anesthesia.
引用
收藏
页码:E580 / E582
页数:3
相关论文
共 50 条
  • [21] Treatment effects on ambulation loss in Spinal Muscular Atrophy Type III: insights from the Italian ISMAC registry
    Coratti, G.
    D'Amico, A.
    Sansone, V.
    Masson, R.
    Maggi, L.
    Mongini, T.
    Pegoraro, E.
    Pini, A.
    Vacchiano, V.
    Coccia, M.
    Filosto, M.
    Ticci, C.
    D'Errico, E.
    Nigro, V.
    Bruno, C.
    Messina, S.
    Pera, M.
    Pane, M.
    Mercuri, E.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [22] Electrical impedance tomography detects changes in ventilation after airway clearance in spinal muscular atrophy type I
    Pigatto, Andre Viera
    Kao, Tzu-Jen
    Mueller, Jennifer L.
    Baker, Christopher D.
    DeBoer, Emily M.
    Kupfer, Oren
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2021, 294
  • [23] Effects of magnetically controlled growing rods surgery on pulmonary function in young subjects with spinal muscular atrophy type 2 and other neuromuscular scoliosis
    Colombo, Luca
    Martini, Carlotta
    Bersanini, Chiara
    Izzo, Francesca
    Villafane, Jorge H.
    Berjano, Pedro
    Lamartina, Claudio
    JOURNAL OF NEUROSURGICAL SCIENCES, 2020, 64 (03) : 253 - 257
  • [24] A case series evaluating patient perceptions after switching from nusinersen to risdiplam for spinal muscular atrophy
    Powell, Jeffrey C.
    Meiling, James B.
    Cartwright, Michael S.
    MUSCLE & NERVE, 2024, 69 (02) : 179 - 184
  • [25] Spinal muscular atrophy (SMA) after conception using gametes from anonymous donors: recommendations for the future
    Callum, Pamela
    Teresa Urbina, Maria
    Falk, Rena E.
    Alvarez-Diaz, Jorge A.
    Benjamin, Isaac
    Sims, Charles A.
    FERTILITY AND STERILITY, 2010, 93 (03) : 1006.e1 - 1006.e2
  • [26] Cardiac arrest after administration of sugammadex as neuromuscular blockade reversal agent and full recovery from anesthesia
    Samara, Evangelia
    Iatrelli, Ioanna
    Georgakis, Theofilos
    Tzimas, Petros
    JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2020, 36 (02) : 268 - 269
  • [27] Spontaneous recovery of neuromuscular blockade is an independent risk factor for postoperative pulmonary complications after abdominal surgery A secondary analysis
    Garutti, Ignacio
    Errando, Carlos L.
    Mazzinari, Guido
    Bellon, Jose M.
    Diaz-Cambronero, Oscar
    Ferrando, Carlos
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2020, 37 (03) : 203 - 211
  • [28] Cortical Reorganizations for Recovery from Depressive State After Spinal Decompression Surgery
    Sawada, Masahiro
    Nakae, Takuro
    Munemitsu, Toshihiro
    Hojo, Masato
    WORLD NEUROSURGERY, 2018, 112 : E632 - E639
  • [29] Clinical outcomes in patients with spinal muscular atrophy type 1, 2 or 3 after 1 year of nusinersen therapy
    Waldrop, M.
    Lowes, L.
    Toops, J.
    Alfano, L.
    Miller, N.
    Iammarino, M.
    Kotha, K.
    Paul, G.
    Moore-Clingenpeel, M.
    Tsao, C.
    Noritz, G.
    Shell, R.
    Flanigan, K.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S188 - S188
  • [30] Improvement in Fine Manual Dexterity in Children with Spinal Muscular Atrophy Type 2 after Nusinersen Injection: A Case Series
    Gu, Minsu
    Kong, Hyun-Ho
    CHILDREN-BASEL, 2021, 8 (11):